Morris Financial Concepts, Inc. Bristol Myers Squibb CO Transaction History

Morris Financial Concepts, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 24, 2023	SELL	$57.89 - $64.73 $4,689 - $5,243	-81 Reduced 2.11%	3,761 $218,000
Q2 2023 Aug 09, 2023	BUY	$63.71 - $70.74 $44,023 - $48,881	691 Added 21.93%	3,842 $245,000
Q1 2023 May 10, 2023	SELL	$65.71 - $74.53 $5,848 - $6,633	-89 Reduced 2.75%	3,151 $218,000
Q4 2022 Jan 19, 2023	BUY	$68.48 - $81.09 $68 - $81	1 Added 0.03%	3,240 $0
Q3 2022 Oct 25, 2022	BUY	$0.13 - $76.84 $23 - $13,677	178 Added 5.82%	3,239 $230,000
Q2 2022 Jul 25, 2022	SELL	$72.62 - $79.98 $9,222 - $10,157	-127 Reduced 3.98%	3,061 $236,000
Q1 2022 Apr 29, 2022	SELL	$61.48 - $73.72 $10,205 - $12,237	-166 Reduced 4.95%	3,188 $233,000
Q4 2021 Feb 15, 2022	BUY	$53.63 - $62.52 $179,875 - $209,692	3,354 New	3,354 $209,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Morris Financial Concepts, Inc., based on Form 13F filings with the SEC.

Stay updated on Morris Financial Concepts, Inc. with notifications on news.